Pharm Delve Cognizance
Aug 16, 2016
To download the pdf version of the Newsletter: Click the following
DelveInsight Newsletter
Downloads
Article in PDF
Recent Articles
- Why should every company working on CAR-T therapy attend CAR TCR Summit Europe?
- Chimeric Antigen Receptor T-cell Therapy Landscape
- Notizia
- Novartis gets CAR-T drug; Shire aims to block; Xeljanz stands; Payer snubs; Lawmakers pass a bill
- Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment
Downloads
Article in PDF
Recent Articles
- Snippet
- Novartis’ Canakinumab for NSCLC; Novartis’s Zolgensma Updates; Trodelvy Prospects in New Breast C...
- Immuno-Oncology (I-O) Therapeutics: The Key to Future Cancer Treatment
- CAR T-Cell Therapies in Non-Hodgkin’s Lymphoma Treatment: A Revolutionary Approach
- Natural Killer Cell Therapies– Advancing technology increasing competition among the companies
